Migrant women and cervical cancer: background of a prevention study

The study was scheduled in order to organize a program of prevention against cervical cancer in female migrants in Rome, and therefore to facilitate access to appropriate preventive oncological facilities for discriminated women. Moreover, the study will also investigate the risk factors and social conditions (HPV-subtypes, sexual behavior, smoking habits) of such women since their migration to Italy. This is scientific and cultural background of a longitudinal, observational study on the cervical cancer risk in Roman migrant population. By means of a mother language questionnaire (with the presence of a cultural mediator) it will be possible to achieve data on social conditions and the new life-style. An HPV-testing (HC2) combined with Pap-test (with further genotype distribution) will be performed in all women enrolled in the study. Further diagnostic/therapeutic decisions will depend on the results of both tests. Scientific results are expected in the next two years, but an increasing of cancer prevention awareness among female migrant populations is expected from the beginning of the program. The present study was aimed at culturally appropriate intervention strategies to limit the disparities that migrants usually suffer in most of the developed Western nations in respect to the native counterparts.

Cervical cancer; Prevention; Migrants; Health discrimination

[1] Department of Economic and Social Affairs, Population Division Staff United Nations: “International Migration Report 2002”, New York, United Nations, 2002.

[2] Newell A., Sullivan A., Halai R., Boag F.: “Sexually transmitted diseases, cervical cytology and contraception in immigrants and refugees from the former Yugoslavia”. Venereology, 1998, 11, 25.

[3] Holk I.K., Rosdahl N., Pedersen K.L.: “Acceptance of mammographic screening by immigrant women”. Ugeskr. Laeger, 2002, 164, 1995.

[4] Norredam M., Krasnik A., Peterson J.H.: “Access to hospital care among immigrant women with breast cancer compared with Danish women”. Ugeskr. Laeger, 1999, 161, 4385.

[5] Ferlay J., Bray F., Pisani P., Parkin D.M., GLOBOCAN 2000: “Cancer incidence, mortality, and prevalence worldwide”. International Agency for Research on Cancer Cancer Base 5, Version 1.0. Lyon: IARC, 2001.

[6] Coleman M.P., Gatta G., Verdecchia A., Estève J., Sant M., Storm H. et al. and the EUROCARE Working Group: “EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century”. Ann. Oncol., 2003, 14 (suppl. 5): v128.

[7] Strategic Action Plan for the Health of Women in Europe. WHO meeting, Copenhagen, 5-7 Feb., 2001.

[8] Ayayi I., Adewole I.: “Knowledge and attitude of general outpatient attendants in Nigeria to cervical cancer”. Centr. Afr. J. Med., 1998, 44, 41.

[9] Boyle P.: “Current situation of screening for cancer”. Ann. Oncol., 2002, 13 (suppl. 4), 189.

[10] Anttila A., Pukkala E., Soderman B., Kallio M., Nieminen P., Hakama M.: “Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence”. Int. J. Cancer, 1999, 83, 59.

[11] Hakama M., Miller A.B., Day N.: “Screening for cancer of the uterine cervix”. IARC Sci Publ., 1986, 76, 161.

[12] Sankaranarayanan R.: “Overview of cervical cancer in the developing world”. Int. J. Gynecol. Obstet., 2006, 95 (suppl. 1), 27th FIGO Annual Report.

[13] Kuhn L., Denny L., Pollack A., Lorincz A., Richart R.M., Wright T.C.: “Human papillomavirus DNA testing for cervical cancer screening in low-resource settings”. J. Nat. Cancer Inst., 2000, 92, 818.

[14] Drain P.K., Holmes K.K., Hyghes J.P., Koutsky L.A.: “Determinants of cervical cancer rates in developing countries”. Int. J. Cancer, 2002, 100, 199.

[15] Bailie R.S., Selvey C.E., Bourne D., Bradshaw D.: “Trends in cervical cancer mortality in South Africa”. Int. J. Epidemiol., 1996, 25, 488.

[16] Royal Thai College of Obstetricians and Gyneacologists (RTOG)/JHPIEGO Corporation Cervical Cancer Prevention Group: “Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project”. Lancet, 2003, 361, 814.

[17] Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S. et al.: “HPV DNA testing in cervical cancer screening”. JAMA, 2000, 283, 87.

[18] Freeman H.: “Cancer in the socioeconomically disadvantaged”. CA Cancer J Clin., 1989, 39, 266.

[19] Ward E., Jemal A., Cokkinides V. et al.: “Cancer Disparities by Race/Ethnicity and Socioeconomic Status”. CA Cancer J. Clin., 2004, 54, 78.

[20] “Cancer facts and figures”, American Cancer Society, 2005.

[21]Giuliano A.R., Papenfuss M., Schneider A., Nour M., Hatch K.: “Risk factors for high-risk type human papillomavirus infection among Mexican-American women”. Cancer Epidemiol. Biomarkers Prev., 1999, 8, 615.

[22] Freeman H.P.: “Poverty, culture, and social injustice determinants of cancer disparities”. CA Cancer J. Clin., 2004, 54, 72.

[23] Merrill R.M., Merrill A.V., Mayer L.S.: “Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women”. Ethn. Dis., 2000, 10, 248.

[24] Shavers V.L., Brown M.L.: “Racial and ethnic disparities in the receipt of cancer treatment”. J. Natl. Cancer Inst., 2002, 94, 334.

[25] Goel M.S., Wee C.C., McCarthy E.P., Davis R.B., Ngo-Metzger Q., Phillips R.S.: “Racial and ethnic disparities in cancer screening. The importance of foreign birth as a barrier to care”. J. Gen. Intern. Med., 2003, 18, 1028.

[26] Nguyen T.T., McPhee S.J., Nguyen T., Lam T., Mock J.: “Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women”. Am. J. Prev. Med., 2002, 23, 207.

[27] Vo P.D., Nguyen T.T.; Nguyen P., Hilton J.F., Palefsky J.; Ma Y., McPhee S.J.: “Human papillomavirus and abnormal pap test results in Vietnamese-American women: a pilot case-control study”. J. Lower Genital Tract. Dis., 2004, 8, 217.

[28] Thomas J.O., Herrero R., Omigbodun A.A., Ojemakinde K., Ajayi, I.O., Fawole A. et al.: “Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study”. Br. J. Cancer, 2004, 90, 638.

[29] De Vuyst H., Steyaert S., Van Renterghem L., Claeys P., Muchiri L., Sitati S. et al.: “Distribution of human papillomavirus in a family planning population in Nairobi, Kenya”. Sex Transm. Dis., 2003, 30, 137.